Addition of Vismodegib to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: vismodegib|DRUG: Paclitaxel|DRUG: Epirubicin|DRUG: Cyclophosphamide
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra